TY  - GEN
AU  - Melchardt,Thomas
AU  - Hufnagl,Clemens
AU  - Magnes,Teresa
AU  - Weiss,Lukas
AU  - Hutarew,Georg
AU  - Neureiter,Daniel
AU  - Schlattau,Alexander
AU  - Moser,Gerhard
AU  - Gaggl,Alexander
AU  - Tränkenschuh,Wolfgang
AU  - Greil,Richard
AU  - Egle,Alexander
TI  - CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
SN  - 1471-2407
PY  - 2016///0629
KW  - Adult
KW  - Aged
KW  - Cisplatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Female
KW  - Fluorouracil
KW  - Genotype
KW  - Head and Neck Neoplasms
KW  - drug therapy
KW  - Humans
KW  - Induction Chemotherapy
KW  - adverse effects
KW  - Male
KW  - Middle Aged
KW  - Polymorphism, Genetic
KW  - Polymorphism, Single Nucleotide
KW  - Steroid Hydroxylases
KW  - genetics
KW  - Taxoids
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s12885-015-1776-x
ER  -